Annual Report

Overview

The report describes Kimia Biosciences' FY2021-22 performance amid pandemic and market volatility, while emphasizing continued pharmaceutical supply and business resilience. It highlights an expanded R&D operation with more than 60 scientists and over 25 commercialized products. The company also states a sustainability agenda covering carbon reduction, renewable energy, water, waste and biodiversity. Its CSR disclosures describe a three-year lake-cleaning and water-conservation project, with the year's CSR obligation transferred to an unspent CSR account.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2021-2022
Period: 1 April 2021 – 31 March 2022
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services